Nebilet Plus 5 mg/25 mg filmom obložene tablete
Name | Nebilet Plus 5 mg/25 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-340964911 |
Active Substance | nebivololklorid hidroklorotiazid |
Composition | jedna tableta Nebileta Plus 5 mg / 25 mg sadrži 5 mg nebivolola (u obliku nebivololklorida: 2,5 mg SRRR-nebivolola ili d-nebivolola i 2,5 mg RSSS-nebivolola ili l-nebivolola) i 25 mg hidroklorotiazida |
Pharmaceutical Form | filmom obložena tableta |
Manufacturer | Berlin-Chemie AG, Berlin, Njemačka
Menarini-Von Heyden GmbH, Dresden, Njemačka A. Menarini Manufacturing Logistics And Services S.r.l., Firenca, Italija |
Marketing Authorisation Holder | Berlin-Chemie Menarini Hrvatska d.o.o., Horvatova 80a, Zagreb, Hrvatska |
Marketing Authorisation Date | 31.08.2017 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/16-02/343 |
Registration Number | 381-12-01/14-17-05 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | C07BB12 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o riziku od nemelanomskog raka kože povezanog s primjenom hidroklorotiazida | 17.10.2018 | Alkaloid, Belupo, Berlin-Chemie Menarini, Boehringer Ingelheim International, Farmal, Genericon, Pharma, Jadran Galenski laboratorij, Krka - farma, Merck, Merck Sharp & Dohme, Novartis, PharmaSwiss, Pliva, Sandoz, sanofi-aventis i Stada |